News and Events

Joe Chinquee volunteers with Navajo Nation during COVID-19 pandemic

Joe Chinquee, D.H.Sc., M.B.A., M.T. (A.S.C.P.) D.L.M., Clinical and Scientific Manager of the Laboratory of Pathology, served on the frontlines of the COVID-19 pandemic. In an effort to give back, he was deployed on a month-long mission to assist the U.S. Public Health Service at the Navajo Nation in New Mexico. Chinquee said: “At the NIH, I’ve been given so many opportunities and rewards. I will never stop giving back, but I would not be able to volunteer for these missions without the full support of my NCI leadership.”

In Memoriam: Flossie Wong-Staal, Ph.D.

The Center for Cancer Research mourns the recent death of past colleague Flossie Wong-Staal. She was a major figure in the discovery of HIV and the first to clone the virus.

Lieutenant and Research Nurse Matt Lindsley shares his experiences and public service role

Matthew Lindsley, MPH, MSN, RN PHNA-BC, is a Lieutenant in the United States Public Health Service. As a Research Nurse Specialist for the NCI’s Center for Cancer Research, Neuro-Oncology Branch, Matt helps patients with brain and spine tumors who come to NIH for treatment. He was recently deployed to aid in the COVID-19 response mission in Washington state for a number of weeks.

Mary Kearney discusses coronavirus with National Geographic

Mary Kearney, Ph.D., Senior Scientist in the Host-Virus Interaction Branch, was recently quoted in a National Geographic article discussing how long coronavirus lasts inside the body. “Where there’s long-term persistence, there can be long-term consequences,” she says.

Clinical trial tests combination therapy for glioblastoma multiforme

Glioblastoma multiforme (GBM) is a type of brain cancer where treatments include radiation therapy, chemotherapy and surgery, but survival rates are poor. Investigators are testing an anticancer drug selinexor, which may make GBM cells less resistant to radiation therapy and allow radiation therapy to kill more cancer cells.

In Memoriam: Gilbert Howlett Smith, Ph.D.

The Center for Cancer Research mourns the recent death of colleague and friend Gilbert Howlett Smith, Ph.D. He was a valued and much liked member of the NCI community since 1965.

Sarcoma Awareness Month

To recognize Sarcoma Awareness Month this July, we are highlighting our researchers who are advancing research discovery in this field. Learn more...

Trial shows aggressive cancer treatment is appropriate for people with HIV-associated primary central nervous system lymphoma

New research from CCR scientists shows that chemoimmunotherapy with antiretroviral therapy can lead to long-lasting remissions of HIV-associated primary central nervous system lymphoma without compromising neurocognitive function.

Study finds drug beneficial for shrinking mesothelioma tumors

A drug that is designed to boost the immune system against mesothelioma, when combined with immunotherapy, was found to be beneficial in a small study involving ten patients. The results suggest that the drug LMB-100 could prolong the life of some patients with advanced disease.

Antibody-dependent cell-mediated cytotoxicity

Clinical trial studies combination therapy for certain mature T-cell cancers that have not responded to treatment

Adult T-cell leukemia/lymphoma (ATLL) and mycosis fungoides/Sézary syndrome (MF/SS) are fast-growing cancers that form in T cells, a type of white blood cell that is key to the body’s immune response. A clinical trial is being conducted at the NIH Clinical Center to test a combination therapy for these rare cancers.

Breadcrumb